Emergingby GlyphXaira Therapeutics launches with $1B for AI drug design
ARCH and Foresite incubated Xaira, which uses protein design models from David Baker's lab.
Synthetic biologytechcrunch.com
Xaira Therapeutics
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| Synthetic biologyAI drug discovery company launched with $1B to design protein and antibody drugs with generative models. | AI drug discovery company launched with $1B to design protein and antibody drugs with generative models. | techcrunch.com |
Events
Funding
$1.0B
Led by ARCH Venture Partners, Foresite Capital
About
- Source
- techcrunch.com (press, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- Xaira Therapeutics on Companies
Xaira Therapeutics
Joined in Synthetic biology. AI drug discovery company launched with $1B to design protein and antibody drugs with generative models.
Xaira Therapeutics
Added in Synthetic biology. AI drug discovery company launched with $1B to design protein and antibody drugs with generative models.